Ledger.Open graph →

SEC Form D · filed January 11, 2016

XERIS PHARMACEUTICALS INC

Offering

$50.0M

Sold

$41.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

AUSTIN, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Cary Mcnair · Austin, TXDirector Navneet Puri · Austin, TXDirector Robert Faulker · Austin, TXDirector Douglas Baum · Austin, TXExec · Director Yash Sabharwal · Austin, TXExec Ariel Garten · Toronto, Ontario, CanadaDirector Gino Demichele · Calgary, Alberta, CanadaExec Thomas Wenz · Calgary, Alberta, CanadaExec · Director Janan Paskaran · Calgary, Alberta, CanadaDirector Jerry Kroll · VANCOUVER, British Columbia, CanadaDirector Phillip Johnson · CAMBRIDGE, NEExec Thomas English · Calgary, Alberta, CanadaDirector William Mason · San Francisco, CADirector Shintaro Yamakami · Tokyo, M0Exec Ed Theobald · VANCOUVER, British Columbia, CanadaDirector Sid Paquette · Toronto, Ontario, CanadaExec · Director Phillip Johnson · Austin, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗